SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-15-050303
Filing Date
2015-02-13
Accepted
2015-02-13 17:03:53
Documents
4
Group Members
JOSHUA WOLFELUX CAPITAL MANAGEMENT, LLCLUX VENTURE ASSOCIATES II, LLCLUX VENTURE PARTNERS II, L.P.LUX VENTURES II SIDECAR, L.P.PETER HEBERT

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d873940dsc13g.htm SC 13G 122743
2 EX-99.1 d873940dex991.htm EX-99.1 20322
3 EX-99.2 d873940dex992.htm EX-99.2 816
4 .EX-99.3 d873940dex993.htm EX-99.3 19655
  Complete submission text file 0001193125-15-050303.txt   165285
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Subject) CIK: 0001457612 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87984 | Film No.: 15616024
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 295 MADISON AVENUE, 24TH FLOOR NEW YORK NY 10017
Business Address 295 MADISON AVENUE, 24TH FLOOR NEW YORK NY 10017 646-475-4385
Lux Ventures II, L.P. (Filed by) CIK: 0001592755 (see all company filings)

IRS No.: 000000000
Type: SC 13G